The Expedited Investigational New Drug Pilot has moved from proposal to implementation. On September 15, 2026, FDA announced the final design and began accepting applications from sponsors preparing first-in-human (FIH) clinical trials in the United States. Applications close at 11:59 p.m. ET on October 30, 2026, and FDA expects to select approximately eight to ten [...]